The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes.
about
Elevated serum fibroblast growth factor 23 levels as an indicator of lower extremity atherosclerotic disease in Chinese patients with type 2 diabetes mellitus.Diabetes, bone and glucose-lowering agents: basic biology.Effect of the water fraction isolated from Fructus Ligustri Lucidi extract on bone metabolism via antagonizing a calcium-sensing receptor in experimental type 1 diabetic rats.Evidence of disordered calcium metabolism in adolescent girls with type 1 diabetes: An observational study using a dual-stable calcium isotope technique.Insulin suppresses the production of fibroblast growth factor 23 (FGF23)SGLT inhibitor adjunct therapy in type 1 diabetes
P2860
The impact of SGLT2 inhibitors, compared with insulin, on diabetic bone disease in a mouse model of type 1 diabetes.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
The impact of SGLT2 inhibitors ...... ouse model of type 1 diabetes.
@en
The impact of SGLT2 inhibitors ...... ouse model of type 1 diabetes.
@nl
type
label
The impact of SGLT2 inhibitors ...... ouse model of type 1 diabetes.
@en
The impact of SGLT2 inhibitors ...... ouse model of type 1 diabetes.
@nl
prefLabel
The impact of SGLT2 inhibitors ...... ouse model of type 1 diabetes.
@en
The impact of SGLT2 inhibitors ...... ouse model of type 1 diabetes.
@nl
P2093
P2860
P1433
P1476
The impact of SGLT2 inhibitors ...... mouse model of type 1 diabetes
@en
P2093
Charles K Lumpkin
Jeffry S Nyman
John L Fowlkes
Katherine L Thompson
Kathryn M Thrailkill
R Clay Bunn
Sasidhar Uppuganti
P2860
P304
P356
10.1016/J.BONE.2016.10.026
P577
2016-10-28T00:00:00Z